What BCIs do
Brain-computer interfaces translate neural activity into commands — restoring movement, communication or sensation to people with paralysis, stroke or neurological disease.
Where the technology stands
Non-invasive BCIs already power assistive devices. Invasive BCIs are advancing rapidly in clinical trials, with implications well beyond their original disability-focused use cases.
Africa's seat at the table
Africa must contribute to BCI research, ethics and policy — not just be a market for finished products. The continent has the talent; what is needed is infrastructure and investment.
Building African BCI research capacity now ensures the continent helps shape — not merely consume — the future of neurotechnology.
Key takeaways
- BCIs are real and clinically advancing
- Most current BCI uses are medical, not enhancement
- Ethical frameworks must include African perspectives
- African neurotech talent exists and needs platforms